These analogs were tested in various mouse and rat models of obesity, glucose intolerance/insulin resistance and T2DM resulting from high-fat (HF) diet feeding (diet-induced obesity (DIO) models) or in rodents with nonfunctional leptin signaling due to a spontaneous mutation in the leptin receptor. Here, LEP is linked to obesity disorder.